Bremer, Sara, Vethe, Nils T, Rootwelt, Helge, Jørgensen, Pål F, Stenstrøm, Jean, Holdaas, Hallvard, ...
Abstract Background Mycophenolic acid (MPA) is widely used as part of immunosuppressive regimens following allograft transplantation. The large pharmacokinetic (PK) and pharmacodynamic (PD)...
Bremer, Sara, Vethe, Nils T, Rootwelt, Helge, Jørgensen, Pål F, Stenstrøm, Jean, Holdaas, Hallvard, ...
BACKGROUND: Mycophenolic acid (MPA) is widely used as part of immunosuppressive regimens following allograft transplantation. The large pharmacokinetic (PK) and pharmacodynamic (PD) variability and...
Long-term clinical outcome of paediatric kidneys transplanted to adults (2008)
Foss, Aksel, Gunther, Anne, Line, Pål-Dag, Brabrand, Knut, Holdaas, Hallvard, Hartmann, Anders, ...
Background. We have earlier shown an increase in the size and excellent graft function of paediatric kidneys transplanted to adults up to 1 year following transplantation. This study was performed to...
Gunther, Anne, Foss, Aksel, Holdaas, Hallvard, Brabrand, Knut, Hartmann, Anders, Line, Paal-Dag, ...
Background. Paediatric kidneys transplanted to adult recipients increase in size after transplantation. It is unknown if the renal artery diameter increases concomitantly with the kidney. This study...
Falck, Pål, Vethe, Nils Tore, Åsberg, Anders, Midtvedt, Karsten, Bergan, Stein, Reubsaet, Jan Leo Egge, ...
Background. The calcimimetic drug cinacalcet offers a novel therapeutic option to treat post-transplant hypercalcemia and hyperparathyroidism; however, the interaction with calcineurin inhibitors and...
Ekberg, Henrik, Kyllonen, Lauri, Madsen, Soren, Grave, Gisle, Solbu, Dag, Holdaas, Hallvard
Abstract is not available
Ekberg, Henrik, Kyllonen, Lauri, Madsen, Søren, Grave, Gisle, Solbu, Dag, Holdaas, Hallvard
Abstract is not available
Soveri, Inga, Holdaas, Hallvard, Jardine, Alan, Gimpelewicz, Claudio, Staffler, Beatrix, Fellström, Bengt
Background. Renal transplant recipients (RTR) mainly die of premature cardiovascular disease. Traditional cardiovascular disease risk factors are prevalent in RTR. Additionally, non-traditional risk...
Soveri, Inga, Holdaas, Hallvard, Jardine, Alan, Gimpelewicz, Claudio, Staffler, Beatrix, Fellström, Bengt
Background. Renal transplant recipients (RTR) mainly die of premature cardiovascular disease. Traditional cardiovascular disease risk factors are prevalent in RTR. Additionally, non-traditional risk...
Soveri, Inga, Holdaas, Hallvard, Jardine, Alan, Gimpelewicz, Claudio, Staffler, Beatrix, Fellström, Bengt
Background. Renal transplant recipients (RTR) mainly die of premature cardiovascular disease. Traditional cardiovascular disease risk factors are prevalent in RTR. Additionally, non-traditional risk...
Soveri, Inga, Holdaas, Hallvard, Jardine, Alan, Gimpelewicz, Claudio, Staffler, Beatrix, Fellström, Bengt
Background. Renal transplant recipients (RTR) mainly die of premature cardiovascular disease. Traditional cardiovascular disease risk factors are prevalent in RTR. Additionally, non-traditional risk...
Soveri, Inga, Holdaas, Hallvard, Jardine, Alan, Gimpelewicz, Claudio, Staffler, Beatrix, Fellström, Bengt
Background. Renal transplant recipients (RTR) mainly die of premature cardiovascular disease. Traditional cardiovascular disease risk factors are prevalent in RTR. Additionally, non-traditional risk...
Fellström, Bengt, Zannad, Faiez, Schmieder, Roland, Holdaas, Hallvard, Jardine, Alan, Rose, Helen, ...
Abstract Background Patients with end-stage renal disease (ESRD) are at high risk of cardiovascular events. Multiple risk factors for atherosclerosis are present in ESRD and may contribute to the...
Fellström, Bengt, Zannad, Faiez, Schmieder, Roland, Holdaas, Hallvard, Jardine, Alan, Rose, Helen, ...
BACKGROUND: Patients with end-stage renal disease (ESRD) are at high risk of cardiovascular events. Multiple risk factors for atherosclerosis are present in ESRD and may contribute to the increased...
Fellström, Bengt, Zannad, Faiez, Schmieder, Roland, Holdaas, Hallvard, Jardine, Alan, Rose, Helen, ...
BACKGROUND: Patients with end-stage renal disease (ESRD) are at high risk of cardiovascular events. Multiple risk factors for atherosclerosis are present in ESRD and may contribute to the increased...
Fellström, Bengt, Zannad, Faiez, Schmieder, Roland, Holdaas, Hallvard, Jardine, Alan, Rose, Helen, ...
BACKGROUND: Patients with end-stage renal disease (ESRD) are at high risk of cardiovascular events. Multiple risk factors for atherosclerosis are present in ESRD and may contribute to the increased...
Fellström, Bengt, Zannad, Faiez, Schmieder, Roland, Holdaas, Hallvard, Jardine, Alan, Rose, Helen, ...
BACKGROUND: Patients with end-stage renal disease (ESRD) are at high risk of cardiovascular events. Multiple risk factors for atherosclerosis are present in ESRD and may contribute to the increased...
Holdaas, Hallvard, Fellström, Bengt, Jardine, Alan G., Nyberg, Gudrun, Grönhagen-Riska, Carola, Madsen, Sören, ...
Background. Renal transplant recipients have a significantly reduced life expectancy, largely due to premature cardiovascular disease. The aim of the current analysis was to investigate the...
Holdaas, Hallvard, Fellström, Bengt, Jardine, Alan G., Nyberg, Gudrun, Grönhagen-Riska, Carola, Madsen, Sören, ...
Background. Renal transplant recipients have a significantly reduced life expectancy, largely due to premature cardiovascular disease. The aim of the current analysis was to investigate the...
Holdaas, Hallvard, Fellström, Bengt, Jardine, Alan G., Nyberg, Gudrun, Grönhagen-Riska, Carola, Madsen, Sören, ...
Background. Renal transplant recipients have a significantly reduced life expectancy, largely due to premature cardiovascular disease. The aim of the current analysis was to investigate the...
The risk of living kidney donation (2003)
Hartmann, Anders, Fauchald, Per, Westlie, Lars, Brekke, Inge B., Holdaas, Hallvard
Atorvastatin improves endothelial function in renal-transplant recipients (2001)
Åsberg, Anders, Hartmann, Anders, Fjeldså, Ellen, Holdaas, Hallvard
Background. Hyperlipidaemia and endothelial dysfunction are common features in cyclosporin A (CsA)‐treated renal transplant recipients. Endothelial dysfunction may contribute to...
Fellström, Bengt, Zannad, Faiez, Schmieder, Roland, Holdaas, Hallvard, Jardine, Alan, Rose, Helen, ...